Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 26.02

+1.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dennis who wrote (1448)	2/19/1999 2:54:00 PM
From: Anthony Wong	Read Replies (1) of 1722

Dennis, MRK has a lower P/E (than other pharmaceuticals) for a reason. Many of its drugs would be off patent in the coming 2-3 years (do a search on MRK in this thread or read the MRK thread). The labpuppy.com site also has a section on patent expiry dates of various drugs. MRK will probably go up some more from now to June because of Vioxx, it's Cox-2 inhibitor competing against MTC/PFE's Celebrex. As a 2-year hold I'm not so certain. LLY has good momentum now, new diabetes drug coming. PFE has a relative high P/E but is a good buy on dips (I'm biased here); read Mr. Peabody's reports at the PFE thread and look for one of the PFE valleys to buy. Labpuppy.com site: labpuppy.com Patent expirations: labpuppy.com Anthony

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next